A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo‐immunized patientsPhuong Vo, Richard Childs, Reem Shalabi et al.|British Journal of Haematology|2020Cited by 30